Related Experiment Video
Updated: Feb 22, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
1National Centre for Cell Science, Pune, India.
Abstract:
Natural killer (NK) cells are innate immune cells that show strong cytolytic function against physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a broad array of tissue distribution and phenotypic variability. NK cells express several activating and inhibitory receptors that recognize the altered expression of proteins on target cells and control the cytolytic function. NK cells have been used in several clinical trials to control tumor growth. However, the results are encouraging only in hematological malignancies but not very promising in solid tumors. Increasing evidence suggests that tumor microenvironment regulate the phenotype and function of NK cells. In this review, we discussed the NK cell phenotypes and its effector function and impact of the tumor microenvironment on effector and cytolytic function of NK cells. We also summarized various NK cell-based immunotherapeutic strategies used in the past and the possibilities to improve the function of NK cell for the better clinical outcome.
Insights
Natural killer (NK) cells are crucial innate immune cells targeting stressed cells. This review explores NK cell function, tumor microenvironment impacts, and immunotherapeutic strategies for improved outcomes, especially in solid tumors.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural killer (NK) cells are innate immune cells with potent cytolytic functions against tumor and virus-infected cells.
- NK cells exhibit diverse tissue distribution and phenotypes, regulated by activating and inhibitory receptors.
- Current NK cell immunotherapies show promise in hematological malignancies but are less effective against solid tumors.
Purpose of the Study:
- To review NK cell phenotypes and effector functions.
- To discuss the influence of the tumor microenvironment on NK cell activity.
- To summarize NK cell-based immunotherapeutic strategies and explore avenues for enhancement.
Main Methods:
- Literature review of NK cell biology and immunotherapies.
- Analysis of studies on NK cell-tumor microenvironment interactions.
- Synthesis of data on clinical trial outcomes and future therapeutic directions.
Main Results:
- NK cell function is significantly modulated by the tumor microenvironment.
- Solid tumors present unique challenges for NK cell-mediated immunotherapy.
- Existing immunotherapeutic strategies require optimization for broader clinical efficacy.
Conclusions:
- Understanding NK cell-tumor microenvironment dynamics is key to improving cancer immunotherapy.
- Novel strategies are needed to enhance NK cell effector functions for solid tumor treatment.
- Further research into NK cell biology and therapeutic engineering holds promise for better clinical outcomes.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Targeted Cancer Therapies
There are several types of targeted therapies against...

